Open access
56
Views
2
CrossRef citations to date
0
Altmetric
Methodology
The EFFECT trial: evaluating exacerbations, biomarkers, and safety outcomes with two dose levels of fluticasone propionate/formoterol in COPD
Alberto Papi1 Department of Internal and CardioRespiratory Medicine, Research Centre on Asthma and COPD, University of Ferrara, Ferrara, ItalyCorrespondence[email protected]
, Paul W Jones2 Institute for Infection and Immunity, St George’s, University of London, London, UK
, Prashant S Dalvi3 Medical Science – Respiratory, Mundipharma Research Ltd, Cambridge, UK
, Kirsten McAulay4 Medical Operations, Mundipharma Research Ltd, Cambridge, UK
, Tammy McIver5 Data Management and Statistics, Mundipharma Research Ltd, Cambridge, UK
& Sanjeeva Dissanayake3 Medical Science – Respiratory, Mundipharma Research Ltd, Cambridge, UK
Pages 2431-2438
|
Published online: 09 Nov 2015
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.